Medicago announces positive Phase 1 results for its COVID-19 vaccine candidate
Medicago announces positive Phase 1 results for its COVID-19 vaccine candidate 100 per cent of subjects who received an adjuvanted vaccine candidate developed significant antibody and cellular immune responses after two doses QUEBEC CITY, Nov. 10, 2020 /CNW/ – Medicago, a biopharmaceutical company headquartered in Quebec City, is pleased to report interim results of the Phase … Continue reading Medicago announces positive Phase 1 results for its COVID-19 vaccine candidate
The Cone+ makes smoking a pre-rolled joint less harmful
The Cone+ makes smoking a pre-rolled joint less harmful THE NETHERLANDS – With the introduction of The Cone+, Dutch company I-nvention is responding to the growing global trend to filter cannabis smoke. The pre-rolled Cone+ joint, in which consumers can put cannabis, comes standard with a patented CTIP™ filter. This cone shaped filter contains high … Continue reading The Cone+ makes smoking a pre-rolled joint less harmful
Licensed clinical Psychologist, Dr. Bethany Cook Shares the Top 7 things to think about before committing and attending family events this 2020 Holiday Season:
Licensed clinical Psychologist, Dr. Bethany Cook Shares the Top 7 things to think about before committing and attending family events this 2020 Holiday Season: Ask Yourself “Is This Good or Bad for My Mental Health?”: Bottom line, if you know a visit to your family will knock you off your “center” the answer is you should not … Continue reading Licensed clinical Psychologist, Dr. Bethany Cook Shares the Top 7 things to think about before committing and attending family events this 2020 Holiday Season:
Health Canada Approves MAVIRET® 8-Week Treatment Duration for Treatment-Naïve Patients with Genotype 3 Compensated Cirrhosis
Health Canada Approves MAVIRET® 8-Week Treatment Duration for Treatment-Naïve Patients with Genotype 3 Compensated Cirrhosis MAVIRET® (glecaprevir/pibrentasvir) is the only 8-week oral treatment approved for all Hepatitis C virus (HCV) Genotypes.1 MAVIRET is indicated for the treatment of chronic HCV infection in adults and adolescent patients 12 to 18 years of age.1 MAVIRET is available and reimbursed … Continue reading Health Canada Approves MAVIRET® 8-Week Treatment Duration for Treatment-Naïve Patients with Genotype 3 Compensated Cirrhosis
PRO+ Dual Respirator masks now manufactured with ground-breaking virucidal coating against COVID-19
PRO+ Dual Respirator masks now manufactured with ground-breaking virucidal coating against COVID-19 The virucidal coating, produced by ZEN Graphene Solutions Ltd., will increase the protection effectiveness of the PRO+ to 99% COLLINGWOOD, ON, Nov. 10, 2020 /CNW/ – As the resurgence of COVID-19 activity continues in Canada, Trebor Rx (Trebor) is resolute in providing the … Continue reading PRO+ Dual Respirator masks now manufactured with ground-breaking virucidal coating against COVID-19
